Enrollment Growth in the ACA Marketplaces

This analysis of enrollment in Affordable Care Act (ACA) Marketplace health plans finds a record 24.3 million people enrolled in 2025, more than double the total in 2020, with most of the growth occurring in states won by President Trump in the 2024 election. In six states, enrollment more than tripled from 2020 to 2025:…

Read More

Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options

[Sponsored] FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease. The post Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options appeared first on MedCity News.

Read More